Publications by authors named "Tracey Guan"
Background: Quality indicators for non-small cell lung cancer (NSCLC) have been implemented in Queensland, Australia, to assess performance across 28 elements relating to diagnosis, access, treatment, and outcomes.
Methods: Linked data were sourced from the population-based Queensland Oncology Repository. Eligible people were diagnosed with NSCLC between 2012 and 2021, with follow-up on treatment and mortality available to 31 December 2022.
Article Synopsis
- Lung cancer is a major health issue in Australia and New Zealand, with 16,000 new cases annually, and variations in care and outcomes have been noted over the years without established benchmarks.
- A study utilized a modified eDelphi consensus process to define clinical quality indicators relevant to lung and thoracic cancer care, involving clinicians, patient advocates, and researchers from across the region.
- Ultimately, 27 clinical quality indicators were agreed upon, aiming to improve the quality of care, with plans for future implementation using real-world data across Australia.
Introduction: Palliative radiotherapy (PRT) is frequently used to treat symptoms of advanced cancer, however benefits are questionable when life expectancy is limited. The 30-day mortality rate after PRT is a potential quality indicator, and results from a recent meta-analysis suggest a benchmark of 16% as an upper limit. In this population-based study from Queensland, Australia, we examined 30-day mortality rates following PRT and factors associated with decreased life expectancy.
View Article and Find Full Text PDFBackground: End-of-life (EOL) chemotherapy administration rates for solid tumours are 12-20% and are associated with a reduced quality of life, increased hospitalisation and incidence of death within an acute care facility.
Aim: We sought to determine the rate of EOL chemotherapy in government and private hospitals and determine the impact on hospitalisations and location of death in lung and pancreatic cancer patients.
Methods: Data were obtained from the Queensland Oncology Repository between 2005 and 2014.
Introduction: We performed a validation study at our institution, the International Union Against Cancer (Union for International Cancer Control latest version of TNM Classification of Malignant Tumors Eighth Edition).
Methods: Data were collected from the Queensland Oncology Online registry of NSCLC or SCLC cases between 2000 and 2015 and validated against the Queensland Integrated Lung Cancer Outcomes Project registry using case identification number, first name, last name, and date of birth. Where data were available, cases were classified according to the Union for International Cancer Control TNM seventh edition stage groupings and then compared with the eighth edition groupings.